Original Research
Published on 25 Nov 2021
A Phase 1, Dose-Ranging Study to Assess Safety and Psychoactive Effects of a Vaporized 5-Methoxy-N, N-Dimethyltryptamine Formulation (GH001) in Healthy Volunteers
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.760671
- 61,395 views
- 46 citations

